Morgan Stanley Initiates Coverage On Arcellx with Overweight Rating, Announces Price Target of $81
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has initiated coverage on Arcellx (NASDAQ:ACLX) with an Overweight rating and set a price target of $81.

March 07, 2024 | 8:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley initiated coverage on Arcellx with an Overweight rating and a price target of $81, indicating a positive outlook.
The initiation of coverage by a major financial institution like Morgan Stanley, especially with an Overweight rating and a significant price target of $81, is a strong positive signal to the market. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100